The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
about
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteersCirculating DNA as biomarker in breast cancerEpigenetic regulation in estrogen receptor positive breast cancer--role in treatment responseBlood-based DNA methylation as biomarker for breast cancer: a systematic reviewMethyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing.Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasisMethylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules.Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients.The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer.The concerted impact of domestication and transposon insertions on methylation patterns between dogs and grey wolves.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiologyQuantitative assessment of the association between APC promoter methylation and breast cancerEpigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Circulating nucleic acids as biomarkers in breast cancer.DNA methylation testing and marker validation using PCR: diagnostic applications.Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.Circulating nucleic acids and protease activities in blood of tumor patients.Hide and seek: tell-tale signs of breast cancer lurking in the blood.DNA methylation and cancer development: molecular mechanism.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.Role of Circulating Cell-Free DNA in Cancers.Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer.Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.Going with the flow: from circulating tumor cells to DNA.Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.DNA promoter hypermethylation profiles in breast duct fluid.Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.Differentially expressed genes in giant cell tumor of bone.Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals.Circulating nucleic acids as a new diagnostic tool
P2860
Q21195201-54F89582-062C-4A90-BD13-381778F43BF0Q26785343-AA1635FA-9EF9-4CF7-A619-91561694FBA3Q27694612-65F004D9-27E6-4B88-94EF-A73BF7709651Q28072075-1BE2B44D-2FDB-4A55-A2EE-8E7A274B2C31Q31030113-D670D8FF-C227-4F19-86F1-F5D08AD50EFDQ33582678-E2C54DF0-07E3-4EE7-AF03-262CF82F245AQ33778433-7D725F51-4F6F-424C-81D7-1B29B9BD7B1BQ33868284-18711FD0-1E9E-4588-9FAD-35DC420439B3Q34267943-8003DC5A-B86C-4B3F-9B8A-65DFBA0CBE5CQ35290472-3838A799-43A1-4E0B-909C-C5F7498FC63AQ35631955-6D9E4679-812F-4E58-8BBA-8203A162D3FAQ35681975-1EC5D12F-5743-4AA7-AAA3-C3E0BB4050C8Q35958967-BDBB796E-188B-4599-B59D-439C29573169Q36091457-5B37D339-C62B-49BE-935D-B2A006661642Q36151111-742B044C-0A02-4442-B2C0-F44F9B7046B2Q36443927-B32CB160-D11F-4D8C-8898-97734E4999FAQ36758695-AEA43BF6-A1A1-4DC3-B882-C9B4CA1AE86AQ36847577-0D71092A-B383-4225-A5A0-1F0D5470EF2FQ37225239-D02BF585-2E8F-4A05-B276-7F28267C9426Q37234443-A6DCD1CB-0A1D-4282-97AC-7ABC0CCC1F3DQ37437350-F35DC15C-351A-4078-B8BD-373AE5C6C9D8Q37639092-44CDEE25-6D22-4A13-B2A1-EC59073368F4Q37690204-3E01C8CB-75AA-421A-A2D4-BBF2051F2328Q37963517-7A2B9384-61F2-4C51-A3C1-9804BDADB192Q38002456-1256749C-D04D-4577-AFB2-592FE8C81F60Q38002907-B8633E0B-62C2-4DB1-A1D7-98F58250437AQ38056383-D5A619FF-9A92-4670-B881-FA53185EFF51Q38091024-0E397888-96DC-48EF-AA79-676097ADCEA5Q38152782-F8AE10F2-104D-4593-8AA5-779C18EB7EA5Q38395321-705690F3-66AD-4EE4-BAF3-5BA64A6E559CQ38591963-506F2C82-08F3-480F-BCAC-78519CDE1FE6Q39783158-0E92D4DB-9590-4A46-8A3B-AD4D5A999263Q43063274-F234DD82-3F99-4DB2-BE19-4546B3E5BF1CQ43826044-53F45D06-8B63-4860-81FF-1F2B70C16744Q50860920-C09DAC9D-2B03-4564-B2FF-53CEB2F0ADB3Q51217671-CC3C40DD-CA72-4ABC-9DBC-999204D199E5Q54484988-256AECF3-7DB5-46E5-8E32-AEB2F44CB817Q54614304-F158A00A-C662-4FCD-9EB5-0307DFD355ECQ55007492-3EA09933-E171-4D17-A4F9-D5AD57649AEDQ58035393-9ED8FEA4-3F43-42FF-A30D-0B9841276C66
P2860
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The presence of circulating to ...... od from breast cancer patients
@en
The presence of circulating to ...... d from breast cancer patients.
@nl
type
label
The presence of circulating to ...... od from breast cancer patients
@en
The presence of circulating to ...... d from breast cancer patients.
@nl
prefLabel
The presence of circulating to ...... od from breast cancer patients
@en
The presence of circulating to ...... d from breast cancer patients.
@nl
P2093
P2860
P356
P1476
The presence of circulating to ...... od from breast cancer patients
@en
P2093
E A Van Marck
I Van der Auwera
P B Vermeulen
S J Van Laere
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605013
P407
P577
2009-04-01T00:00:00Z